Inventiva (IVA) Exchange Rate Effect (2021 - 2025)
Inventiva (IVA) posted quarterly Exchange Rate Effect of $2.4 million for Q4 2022, down 28.16% year-over-year from $3.4 million in Q4 2021, and up 171.16% quarter-over-quarter from -$3.4 million in Q3 2022.
Powered by 
Analysis
Inventiva (IVA) Exchange Rate Effect (2021 - 2025) Analysis & Trends
Inventiva's Exchange Rate Effect history runs 2 years deep, the most recent figure standing at $2.4 million for Q4 2022.
- In Q4 2022, Exchange Rate Effect fell 28.16% year-over-year to $2.4 million; the TTM figure through Dec 2022 stood at $10.4 million (changed N/A YoY), while the FY2025 annual figure was -$544772.4, down 141.21% from the prior year.
- Exchange Rate Effect for Q4 2022 stood at $2.4 million, up from -$3.4 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $8.0 million in Q2 2021, with the low at -$4.4 million in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -842,178.01 |
| Dec 31, 2022 | 2.44 Mn |
| Sep 22, 2022 | 2.49 Mn |
| Dec 31, 2021 | 3.39 Mn |
| Jun 30, 2021 | 2.58 Mn |
| Mar 31, 2021 | -4.42 Mn |